269731-39-7Relevant articles and documents
N-3-substituted imidazoquinazolinones: Potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction
Rotella, David P.,Sun, Zhong,Zhu, Yeheng,Krupinski, John,Pongrac, Ronald,Seliger, Laurie,Normandin, Diane,Macor, John E.
, p. 1257 - 1263 (2007/10/03)
Phosphodiesterase type 5 (PDE5) inhibitors with improved PDE isozyme selectivity relative to sildenafil may result in agents for the treatment of male erectile dysfunction (MED) with a lower incidence of PDE-associated adverse effects. This paper describe